Alimera Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022, and Provide Corporate Update
Alimera Sciences (Nasdaq: ALIM) will report Q4 and full-year 2021 financial results on February 24, 2022, before market open. A conference call will be held at 9:00 AM ET to discuss the results and corporate updates. Pre-registration is encouraged for a smoother experience, while alternative dial-in options are available for those unable to register online. The call will also be accessible via a live webcast. A replay of the call will be available for a limited time following the event.
- None.
- None.
Conference Call to be held Thursday, February 24, 2022, at 9:00am Eastern Time
ATLANTA, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report fourth quarter and full year 2021 financial results on Thursday, February 24, 2022, prior to the market open.
Management will host a conference call at 9:00 AM ET on the same day, to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.
Participants are asked to pre-register for the call.
Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.
The conference call will also be available through a live webcast, which is also available through the company’s website.
A webcast replay of the call will be available approximately one hour after the end of the call through May 24, 2022. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 2238986. The telephonic replay will be available until March 10, 2022.
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com | For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
FAQ
When will Alimera report its fourth quarter 2021 earnings?
What time is the Alimera conference call scheduled for?
How can I access the Alimera conference call?